Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

    This grant will provide access to TOPMed resources for researchers to generate and share large-scale genetic and multi-omics data to study the molecular mechanisms of heart, lung, blood, and sleep disorders.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

    This upcoming NIH grant will fund innovative research developing advanced bioinformatics and computational biology tools to improve biomedical data analysis and health outcomes, encouraging interdisciplinary and technology-driven projects.

    HHS-NIH11Due Mar 5, 2029$250,000

    Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

    NHGRI seeks applications to study how genomic variations affect genome function and phenotypes using high-throughput methods, as part of the IGVF Consortium.

    HHS-NIH11Due Dec 14, 2026$2,000,000

    GREGoRi Innovation Projects (U01 Clinical Trial Optional)

    NHGRI will fund pilot studies using innovative molecular technologies, beyond standard DNA sequencing, to identify genes or variants causing rare genetic disorders, with applications opening in 2026.

    HHS-NIH11Due Oct 30, 2026· 4d$500,000

    NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

    Supporting early phase clinical trials for heart, lung, blood, and sleep disorders in both adults and children, with applicants expected to be ready to start trials within the initial project period.

    HHS-NIH11Due Feb 3, 2027$4,545,000

    NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

    Funds Phase I clinical trials for diagnostic/therapeutic interventions in heart, lung, blood, and sleep disorders in adults/children, allowing preclinical activities and milestone-driven support.

    HHS-NIH11Due Feb 3, 2027$5,045,000